Precigen (PGEN) Asset Utilization Ratio (2013 - 2026)

Precigen's (PGEN) quarterly Asset Utilization Ratio came in at 0.22 in Q1 2026, up 432.25% year-on-year from 0.04 in Q1 2025, and up 233.81% on a QoQ basis from 0.07 in Q4 2025.

Precigen (PGEN) Asset Utilization Ratio (2013 - 2026) Analysis & Trends

Precigen (PGEN) has 14 years of Asset Utilization Ratio data on file, last reported at 0.22 in Q1 2026.

  • On a quarterly basis, Asset Utilization Ratio rose 432.25% year-over-year to 0.22 in Q1 2026; TTM through Mar 2026 was 0.22, a 432.25% increase from a year earlier, with the FY2025 full-year figure at 0.06, up 143.07% from the prior year.
  • Asset Utilization Ratio for Q1 2026 stood at 0.22, up from 0.07 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for PGEN reached as high as 0.22 in Q1 2026 and fell as low as 0.06 in Q3 2023.
  • Historically, Asset Utilization Ratio has averaged 0.04 across 5 years, with a median of 0.04 in 2022.
  • Across the five-year window, Asset Utilization Ratio tumbled 243.59% in 2023 and soared 432.25% in 2026, its largest moves.
  • Year by year, Asset Utilization Ratio stood at 0.04 in 2022, then slumped by 51.0% to 0.02 in 2023, then soared by 172.91% to 0.05 in 2024, then soared by 39.8% to 0.07 in 2025, then soared by 233.81% to 0.22 in 2026.
  • Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.22 in Q1 2026, 0.07 in Q4 2025, and 0.05 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.69
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 0.47
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 0.37
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Precigen 1.96 Bn 1.96 Bn 20.69 Mn 0.22

Historic Data

Download Data
DateValue
Mar 31, 2026 0.22
Dec 31, 2025 0.07
Sep 30, 2025 0.05
Jun 30, 2025 0.05
Mar 31, 2025 0.04
Dec 31, 2024 0.05
Sep 30, 2024 0.04
Jun 30, 2024 0.03
Mar 31, 2024 0.03
Dec 31, 2023 0.02
Sep 30, 2023 -0.06
Jun 30, 2023 0.01
Mar 31, 2023 0.01
Dec 31, 2022 0.04
Sep 30, 2022 0.04
Jun 30, 2022 0.01
Mar 31, 2022 0.01
Dec 31, 2021 0.06
Sep 30, 2021 0.13
Jun 30, 2021 0.18